Community pages



News story: Access Consortium strategy launched The Access Consortium has published a three-year strategy which aims to align regulatory approaches and policies to facilitate work-sharing on medicines
CAS Number: 179474-79-4
Metrochem API Pvt Ltd
Covid: Fifth of England hospital admissions aged 18-34 The new NHS chief executive urges unvaccinated young adults to get jabbed, saying it is "so important".
Covid: Pressured oxygen reduces ventilator need A study should improve care for patients and prevent oxygen supplies being wasted.


Whether you’re a buyer or a supplier the iOPharma™ platform will benefit your organisation.

More efficient.
More profitable.

Find new trading partners and manage your transactions through every step of the Pharmaceutical supply chain from Quoting to Shipping.

Whether you're a buyer or a supplier the iOPharma platform will benefit your organisation.

Register NOW →

News from iOPharmaTM

  • 17 Feb 2015 04:39 GMT Doctors on social media slam NICE diabetes guidance
    Doctors are seemingly outraged by new draft guidelines on the treatment of diabetes published by the National Institute for Health and Care Excellence, according to a recent study of conversations among healthcare professionals in social media. Read more at: More
  • 14 Feb 2015 13:32 GMT Pharma is boosting pipelines to avoid patent cliff
    Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors Service. The firm that produces reports around the financial outlook of companies and countries says pharma has improved its pipelines of new drugs, ... More
  • 11 Feb 2015 13:32 GMT Uruguay Marijuana Licenses Lure Bidders From Canada to Germany
    (Bloomberg) — Canadian medical-marijuana producer Tilray and the founder of a German cannabis products retailer are among 11 investors bidding for a foothold in a formerly illegal industry in Uruguay: marijuana farms. Once the government issues the licenses, pot could reach pharmacies in th... More
  • 26 Jan 2015 05:34 GMT AstraZeneca plc Lowered to “Underweight” at Barclays
    Barclays lowered shares of AstraZeneca plc (LON:AZN) to an underweight rating in a research report released on Friday morning. Barclays has also modified their ratings on a number of other stocks in the few days. The firm lowered its price target on shares of Goldcorp Inc. from $30.00 to $26.00. ... More
  • 23 Jan 2015 05:28 GMT Institute of Medicine Maps Out Clinical Trial Data Sharing Program
    Investigators and sponsors of clinical trials will have to make more detailed data available following study completion, according to a new report from an Institute of Medicine expert panel, but they will have several months to disclose individual case reports and complete data supporting registr... More